Malignancy risk in systemic Lupus Erythematosus patients treated with cyclophosphamide
dc.authorid | Karadag, Omer/0000-0002-3443-3117 | |
dc.authorid | Ozen, Gulsen/0000-0002-5423-393X | |
dc.authorid | Aksu, Kenan/0000-0001-8889-2688 | |
dc.authorid | erken, eren/0000-0001-6902-624X | |
dc.authorid | Coşkun, Belkıs Nihan/0000-0003-0298-4157 | |
dc.authorid | Karadag, Omer/0000-0002-3443-3117 | |
dc.authorid | Yıldız, Fatih/0000-0003-3628-8870 | |
dc.authorwosid | Karadag, Omer/AAR-4219-2020 | |
dc.authorwosid | Ozen, Gulsen/J-4547-2016 | |
dc.authorwosid | Aksu, Kenan/HLH-8218-2023 | |
dc.authorwosid | erken, eren/L-3219-2019 | |
dc.authorwosid | Coşkun, Belkıs Nihan/AAG-7155-2021 | |
dc.authorwosid | Karadag, Omer/AAD-5448-2019 | |
dc.authorwosid | Yıldız, Fatih/P-2555-2018 | |
dc.contributor.author | Yilmaz, N. | |
dc.contributor.author | Emmungil, H. | |
dc.contributor.author | Gucenmez, S. | |
dc.contributor.author | Ozen, G. | |
dc.contributor.author | Yildiz, F. | |
dc.contributor.author | Balkarli, A. | |
dc.contributor.author | Kimyon, G. | |
dc.date.accessioned | 2024-06-12T11:24:01Z | |
dc.date.available | 2024-06-12T11:24:01Z | |
dc.date.issued | 2015 | |
dc.department | Trakya Üniversitesi | en_US |
dc.description | 11th International Congress on Systemic Lupus Erythematosus -- SEP 02-06, 2015 -- Vienna, AUSTRIA | en_US |
dc.description.abstract | [Abstract Not Available] | en_US |
dc.identifier.endpage | S67 | en_US |
dc.identifier.issn | 0392-856X | |
dc.identifier.issn | 1593-098X | |
dc.identifier.issue | 3 | en_US |
dc.identifier.startpage | S67 | en_US |
dc.identifier.uri | https://hdl.handle.net/20.500.14551/26776 | |
dc.identifier.volume | 33 | en_US |
dc.identifier.wos | WOS:000360421900240 | en_US |
dc.identifier.wosquality | Q2 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.language.iso | en | en_US |
dc.publisher | Clinical & Exper Rheumatology | en_US |
dc.relation.ispartof | Clinical And Experimental Rheumatology | en_US |
dc.relation.publicationcategory | Konferans Öğesi - Uluslararası - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | [No Keywords] | en_US |
dc.title | Malignancy risk in systemic Lupus Erythematosus patients treated with cyclophosphamide | en_US |
dc.type | Conference Object | en_US |